Volume 21, Issue 4, Pages (April 2014)

Slides:



Advertisements
Similar presentations
Pratistha Ranjitkar, Amanda M. Brock, Dustin J. Maly 
Advertisements

Switching Heterotrimeric G Protein Subunits with a Chemical Dimerizer
Ambiguous Origin: Two Sides of an Ephrin Receptor Tyrosine Kinase
Federico Dajas-Bailador, Emma V. Jones, Alan J. Whitmarsh 
Ready, Set, Go! How Protein Kinase C Manages Dynamic Signaling
Protein Kinase C Regulation: C1 Meets C-tail
Erica M. Dutil, Alex Toker, Alexandra C. Newton  Current Biology 
Volume 36, Issue 4, Pages (November 2009)
Volume 25, Issue 1, Pages e8 (January 2018)
Volume 19, Issue 8, Pages (August 2012)
Volume 18, Issue 11, Pages (November 2010)
Long-Range Ca2+ Signaling from Growth Cone to Soma Mediates Reversal of Neuronal Migration Induced by Slit-2  Chen-bing Guan, Hua-tai Xu, Ming Jin, Xiao-bing.
Volume 23, Issue 8, Pages (August 2015)
Volume 15, Issue 4, Pages (April 2008)
Phospho-Pon Binding-Mediated Fine-Tuning of Plk1 Activity
Coiled Coils Direct Assembly of a Cold-Activated TRP Channel
Volume 21, Issue 8, Pages (August 2014)
Beena Krishnan, Lila M. Gierasch  Chemistry & Biology 
Volume 160, Issue 3, Pages (January 2015)
Positive-Feedback Loops as a Flexible Biological Module
Yuan Yang, Chang Shu, Pingwei Li, Tatyana I. Igumenova 
Volume 21, Issue 2, Pages (February 2014)
Volume 16, Issue 12, Pages (December 2009)
Charlene Depry, Sohum Mehta, Ruojing Li, Jin Zhang  Chemistry & Biology 
Volume 18, Issue 12, Pages (December 2010)
Sanjay B. Hari, Ethan A. Merritt, Dustin J. Maly  Chemistry & Biology 
Volume 13, Issue 1, Pages (January 2006)
Binding of OTULIN to the PUB Domain of HOIP Controls NF-κB Signaling
Volume 17, Issue 2, Pages (January 2007)
Volume 23, Issue 2, Pages (April 2018)
Volume 37, Issue 5, Pages (March 2010)
Volume 18, Issue 4, Pages (April 2011)
Volume 24, Issue 12, Pages e5 (December 2017)
Volume 41, Issue 5, Pages (March 2011)
Gain-of-function mutations in protein kinase Cα (PKCα) may promote synaptic defects in Alzheimer’s disease by Stephanie I. Alfonso, Julia A. Callender,
Volume 24, Issue 4, Pages e5 (April 2017)
Volume 21, Issue 3, Pages (March 2013)
Volume 24, Issue 7, Pages (March 2014)
Volume 23, Issue 9, Pages (September 2015)
Volume 20, Issue 8, Pages (August 2013)
Direct Activation of Epac by Sulfonylurea Is Isoform Selective
Volume 20, Issue 9, Pages (September 2013)
A General Framework for Inhibitor Resistance in Protein Kinases
Volume 20, Issue 6, Pages (June 2013)
Volume 22, Issue 11, Pages (November 2015)
Satoru Funamoto, Ruedi Meili, Susan Lee, Lisa Parry, Richard A. Firtel 
Protein Kinase D Inhibitors Uncouple Phosphorylation from Activity by Promoting Agonist-Dependent Activation Loop Phosphorylation  Maya T. Kunkel, Alexandra C.
Conformation-Selective ATP-Competitive Inhibitors Control Regulatory Interactions and Noncatalytic Functions of Mitogen-Activated Protein Kinases  Sanjay B.
Volume 17, Issue 10, Pages (October 2010)
Volume 16, Issue 6, Pages (March 2006)
Volume 160, Issue 3, Pages (January 2015)
Mst1 Is an Interacting Protein that Mediates PHLPPs' Induced Apoptosis
Ligand-Driven Vectorial Folding of Ribosome-Bound Human CFTR NBD1
Pratistha Ranjitkar, Amanda M. Brock, Dustin J. Maly 
Mechanism of Persistent Protein Kinase D1 Translocation and Activation
Volume 105, Issue 1, Pages (April 2001)
Volume 12, Issue 6, Pages (June 2005)
Volume 21, Issue 10, Pages (October 2014)
Regulation of LKB1/STRAD Localization and Function by E-Cadherin
Jue Wang, Jia-Wei Wu, Zhi-Xin Wang  Structure 
Volume 26, Issue 4, Pages e4 (April 2018)
Structure of the Siz/PIAS SUMO E3 Ligase Siz1 and Determinants Required for SUMO Modification of PCNA  Ali A. Yunus, Christopher D. Lima  Molecular Cell 
A Fluorescent Reporter of AMPK Activity and Cellular Energy Stress
Interaction with AKAP79 Modifies the Cellular Pharmacology of PKC
Volume 23, Issue 7, Pages (July 2016)
Volume 28, Issue 3, Pages e4 (February 2018)
Volume 24, Issue 3, Pages (March 2017)
A Splicing-Independent Function of SF2/ASF in MicroRNA Processing
A Common Phosphate Binding Site Explains the Unique Substrate Specificity of GSK3 and Its Inactivation by Phosphorylation  Sheelagh Frame, Philip Cohen,
Elena Oancea, Tobias Meyer  Cell 
Presentation transcript:

Volume 21, Issue 4, Pages 459-469 (April 2014) Intramolecular Conformational Changes Optimize Protein Kinase C Signaling  Corina E. Antal, Jonathan D. Violin, Maya T. Kunkel, Søs Skovsø, Alexandra C. Newton  Chemistry & Biology  Volume 21, Issue 4, Pages 459-469 (April 2014) DOI: 10.1016/j.chembiol.2014.02.008 Copyright © 2014 Elsevier Ltd Terms and Conditions

Chemistry & Biology 2014 21, 459-469DOI: (10. 1016/j. chembiol. 2014 Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 1 Maturation of PKC Retards Agonist-Dependent Membrane Translocation Kinetics (A) Schematic of cPKCs and nPKCs showing domain composition with the C1A and C1B domains (orange) and the C2 domain (yellow). The W and Y are the Trp and Tyr residues at position 22 within the C1A (W58 in PKCβII) or C1B (Y123 in PKCβII) domains of cPKCs that dictate membrane affinity. nPKCs contain Trp at both of these sites. The kinase domain (cyan) and the three priming phosphorylations are shown: the activation loop, turn motif, and hydrophobic motif. (B) Ribbon structure of the kinase domain of PKCβII (Protein Data Bank [PDB] ID 2I0E) showing the three priming phosphorylations in stick form (Thr500, activation loop; Thr641, turn motif; and Ser600, hydrophobic motif) and the kinase-inactivating mutations (Lys371 and AspD466 in the active site and Pro616 and Pro619 in the PXXP motif) in ball form. (C) Representative images displaying localization of the indicated YFP- and RFP-tagged PKCs, cotransfected into COS7 cells, before (top), after 2.5 min (middle), or after 12.5 min (bottom) of PDBu treatment are shown. (D) Western blot displaying whole-cell lysates of COS7 cells transfected with the indicated PKCβII constructs. The asterisk denotes the position of mature, fully phosphorylated PKCβII, and the dash denotes the position of unphosphorylated PKCβII. Chemistry & Biology 2014 21, 459-469DOI: (10.1016/j.chembiol.2014.02.008) Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 2 An Intramolecular FRET Reporter Reads Conformational Transitions of PKC in Live Cells (A) Diagram of Kinameleon showing CFP on the N terminus and YFP on the C terminus of PKC; schematic of how very low FRET reflects an unprimed conformation (upper panel), intermediate FRET reflects a mature (phosphorylated at the activation loop in pink, turn motif in orange, and hydrophobic motif in green) but inactive conformation (middle panel), and high FRET reflects an active conformation (lower panel). (B) Pseudocolor FRET ratio images (left) and localization (right) of MDCK cells transiently expressing Kinameleon-K371R (representing unprocessed PKC), Kinameleon-WT (representing mature, phosphorylated, but inactive PKC), Kinameleon-WT after 15 min of PDBu treatment (representing mature, active PKC), and Kinameleon-WT after 12 hr of PDBu treatment (representing dephosphorylated PKC), depict different PKC conformations. (C) Quantitation of the FRET ratios ± SEM of Kinameleon-WT post-PDBu treatment of cells and of Kinameleon-K371R in the absence of PDBu treatment. (D) Kinameleon expressed in MDCK cells and stimulated with 200 nM PDBu results in increased FRET, shown as a change in the FRET ratio (upper panel). The increasing FRET change with higher expression levels (linear regression in red, with 95% confidence bands in green) indicates an intermolecular (concentration-dependent) interaction. The non-zero y-intercept indicates an intramolecular (concentration-independent) interaction, consistent with a conformational change upon translocation. In contrast, co-expression of CFP-PKCβII-CFP and YFP-PKCβII-YFP shows only an intermolecular interaction after 200 nM PDBu (lower panel). Chemistry & Biology 2014 21, 459-469DOI: (10.1016/j.chembiol.2014.02.008) Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 3 Translocation Kinetics of the Isolated C1A-C1B Domain of PKCβII Can Be Tuned by a Single Residue (A) Ribbon structure of the C1B domain of PKCα (PDB ID 2ELI) showing the DAG affinity toggle, Tyr at position 22 in the domain (Tyr123 in PKCα and PKCβ). This residue is present as Trp (Trp58) in the C1A domain of PKCα and PKCβ. (B) COS7 cells transfected with the indicated C1A-C1B constructs flanked by CFP and YFP were monitored for their intermolecular FRET ratio ± SEM upon PDBu stimulation. (C) Representative YFP images of the basal localization of wild-type or mutant C1A-C1B domains. (D) Trace showing translocation kinetics of the C1A-C1B domain ± SEM with subsaturating levels of phorbol esters (50 nM PDBu), followed by saturating amounts of PDBu to yield a final concentration of 200 nM. Chemistry & Biology 2014 21, 459-469DOI: (10.1016/j.chembiol.2014.02.008) Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 4 Unprimed cPKCs Have an Exposed C1A-C1B Tandem Module that Is Masked upon Maturation (A) The FRET ratios of COS7 cells cotransfected with membrane-targeted CFP and the indicated full-length, YFP-tagged PKCβII constructs were monitored upon PDBu treatment. Plots show data normalized to 100% for the maximal FRET response ± SEM. (B) Western blot of whole-cell lysates of COS7 cells transfected with the indicated HA-PKCα constructs. The asterisk denotes the position of mature, fully phosphorylated PKCα, and the dash denotes the position of unphosphorylated PKCα. (C) FRET ratios ± SEM of COS7 cells cotransfected with membrane-targeted CFP and the indicated full-length, YFP-tagged PKCα constructs were monitored upon PDBu stimulation. (D) FRET ratios ± SEM of COS7 cells cotransfected with membrane-targeted CFP and the indicated full-length, YFP-tagged PKCβII constructs were monitored upon stimulation with a subsaturating PDBu concentration for wild-type PKCβII (50 nM), followed by treatment with another 150 nM PDBu to evoke a maximal response. Chemistry & Biology 2014 21, 459-469DOI: (10.1016/j.chembiol.2014.02.008) Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 5 Both the C1A and C1B Domains of Unphosphorylated PKCs Are Exposed and Become Masked upon Priming of PKC (A–D) FRET ratios ± SEM of COS7 cells cotransfected with membrane-targeted CFP and the indicated full-length, YFP-tagged PKCβII constructs were monitored upon PDBu treatment. (E) Representative YFP images of localization of the indicated PKCβII or PKCδ mutants before (top) or after (bottom) PDBu treatment. Chemistry & Biology 2014 21, 459-469DOI: (10.1016/j.chembiol.2014.02.008) Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 6 The C1A and C1B Domains Are Involved in Membrane Binding, but the C1B Domain Dominates The FRET ratios ± SEM of COS7 cells cotransfected with membrane-targeted CFP and the indicated full-length, YFP-tagged PKCβII constructs were monitored upon stimulation with the PKC agonists DiC8 and PDBu. Chemistry & Biology 2014 21, 459-469DOI: (10.1016/j.chembiol.2014.02.008) Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 7 Model Showing How Maturation of cPKC Masks C1 Domains to Increase the Dynamic Range of DAG Sensing and thus PKC Output (A) Unprimed PKC is in an open conformation that associates with membranes via weak interactions from the C2 domain, both C1A and C1B domains, the exposed pseudosubstrate, and the C-terminal tail. In this conformation, both C1A and C1B domains are fully exposed. (B) Upon ordered phosphorylation of PKC at its activation loop (pink), turn motif (orange), and hydrophobic motif (green) sites, PKC matures into its closed conformation, in which both the C1A and C1B domains become masked, the pseudosubstrate binds the substrate binding site, and the enzyme localizes to the cytosol. This masking of the C1 domains prevents pretargeting of PKC to membranes in the absence of agonist-evoked increases in DAG, thus decreasing basal signaling. (C) In response to agonists that promote PIP2 hydrolysis, Ca2+-dependent binding of the C2 domain of cPKCs to the plasma membrane allows the low-affinity DAG sensor to find its membrane-embedded ligand, DAG. (D) Binding of DAG, predominantly to the C1B domain of PKCβII, expels the pseudosubstrate from the substrate-binding cavity and activates PKC. Use primarily of the lower-affinity C1B domain increases the dynamic range of PKC output because the signal does not saturate as readily using the lower affinity module and allows cPKCs to signal at the plasma membrane as opposed to the Golgi. (E) Dephosphorylation of activated PKC allows it to regain the exposed (open) conformation of unprimed PKC. Chemistry & Biology 2014 21, 459-469DOI: (10.1016/j.chembiol.2014.02.008) Copyright © 2014 Elsevier Ltd Terms and Conditions